Search Results - "ALGABA, Ferran"

Genetic dissection of spermatogenic arrest through exome analysis: clinical implications for the management of azoospermic men by Krausz, Csilla, Riera-Escamilla, Antoni, Moreno-Mendoza, Daniel, Holleman, Kaylee, Cioppi, Francesca, Algaba, Ferran, Pybus, Marc, Friedrich, Corinna, Wyrwoll, Margot J., Casamonti, Elena, Pietroforte, Sara, Nagirnaja, Liina, Lopes, Alexandra M., Kliesch, Sabine, Pilatz, Adrian, Carrell, Douglas T., Conrad, Donald F., Ars, Elisabet, Ruiz-Castañé, Eduard, Aston, Kenneth I., Baarends, Willy M., Tüttelmann, Frank

“…Purpose Azoospermia affects 1% of men and it can be the consequence of spermatogenic maturation arrest (MA). Although the etiology of MA is likely to be of…”
Get full text

Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups by van Kessel, Kim E M, van der Keur, Kirstin A, Dyrskjøt, Lars, Algaba, Ferran, Welvaart, Naeromy Y C, Beukers, Willemien, Segersten, Ulrika, Keck, Bastian, Maurer, Tobias, Simic, Tatjana, Horstmann, Marcus, Grimm, Marc-Oliver, Hermann, Gregers G, Mogensen, Karin, Hartmann, Arndt, Harving, Niels, Petersen, Astrid C, Jensen, Jørgen B, Junker, Kerstin, Boormans, Joost L, Real, Francisco X, Malats, Núria, Malmström, Per-Uno, Ørntoft, Torben F, Zwarthoff, Ellen C

“…The European Association of Urology (EAU) guidelines for non-muscle-invasive bladder cancer (NMIBC) recommend risk stratification based on clinicopathologic…”
Get full text

Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours by Vedder, Moniek M, Márquez, Mirari, de Bekker-Grob, Esther W, Calle, Malu L, Dyrskjøt, Lars, Kogevinas, Manoils, Segersten, Ulrika, Malmström, Per-Uno, Algaba, Ferran, Beukers, Willemien, Ørntoft, Torben F, Zwarthoff, Ellen, Real, Francisco X, Malats, Nuria, Steyerberg, Ewout W

“…We aimed to determine the validity of two risk scores for patients with non-muscle invasive bladder cancer in different European settings, in patients with…”
Get full text

Unclassified renal cell carcinoma: a report of 56 cases by Lopez‐Beltran, Antonio, Kirkali, Ziya, Montironi, Rodolfo, Blanca, Ana, Algaba, Ferran, Scarpelli, Marina, Yorukoglu, Kutsal, Hartmann, Arndt, Cheng, Liang

“…Study Type – Therapy (case series) Level of Evidence 4 What's known on the subject? and What does the study add? Unclassified RCC represents 0.7–5.7% of renal…”
Get full text

A Second-Look TUR in T1 Transitional Cell Carcinoma: Why? by Jakse, Gerhard, Algaba, Ferran, Malmström, Per-Uno, Oosterlinck, Willem

“…T1 transitional cell cancer of the urinary bladder is associated with a significant risk of tumor progression when transurethral resection (TUR) is the only…”
Get full text

KISS1 Methylation and Expression as Tumor Stratification Biomarkers and Clinical Outcome Prognosticators for Bladder Cancer Patients by Cebrian, Virginia, Fierro, Marta, Orenes-Piñero, Esteban, Grau, Laura, Moya, Patricia, Ecke, Thorsten, Alvarez, Miguel, Gil, Marta, Algaba, Ferran, Bellmunt, Joaquin, Cordon-Cardo, Carlos, Catto, James, López-Beltrán, Antonio, Sánchez-Carbayo, Marta

“…KISS1 is a metastasis suppressor gene that is lost in several malignancies, including bladder cancer. We tested the epigenetic silencing hypothesis and…”
Get full text

Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Clinicopathologic Findings and LOH Analysis by LOPEZ-BELTRAN, Antonio, AMIN, Mahul B, OLIVEIRA, Pedro S, MONTIRONI, Rodolfo, ALGABA, Ferran, MCKENNEY, Jesse K, DE TORRES, Ines, MAZEROLLES, Catherine, MINGSHENG WANG, LIANG CHENG

“…In this report, we present the clinicopathologic features of 27 cases of the lipid cell variant of urothelial bladder carcinoma. This is a rare variant of…”
Get full text

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members by Beijert, Irene J., Cheng, Liang, Liedberg, Fredrik, Plass, Karin, Williamson, Sean R., Gontero, Paolo, Ribal, Maria J., Babjuk, Marko, Black, Peter C., Kamat, Ashish M., Algaba, Ferran, Berman, David M., Hartmann, Arndt, Masson-Lecomte, Alexandra, Rouprêt, Morgan, Lopez-Beltran, Antonio, Samaratunga, Hemamali, Shariat, Shahrokh F., Mostafid, A. Hugh, Varma, Murali, Shen, Steven, Burger, Maximilian, Tsuzuki, Toyonori, Palou, Joan, Compérat, Eva M., Sylvester, Richard J., van der Kwast, Theo H., van Rhijn, Bas W.G., Downes, Michelle R.

“…Both the World Health Organization (WHO) 1973 and WHO2004 grading systems are used widely. However, there was limited support for WHO1973 and WHO2004 in their…”
Get full text

Flat urothelial carcinoma in situ of the bladder with glandular differentiation by Lopez-Beltran, Antonio, MD, PhD, Jimenez, Rafael E., MD, Montironi, Rodolfo, MD, Patriarca, Carlo, MD, Blanca, Ana, PhD, Menendez, Carmen L., MD, Algaba, Ferran, MD, Cheng, Liang, MD

“…Summary We present the clinicopathologic and immunonohistochemical features of 25 cases of flat urothelial carcinoma in situ with glandular differentiation…”
Get full text

Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies by Montironi, Rodolfo, Mazzuccheli, Roberta, Scarpelli, Marina, Lopez‐Beltran, Antonio, Fellegara, Giovanni, Algaba, Ferran

“…The Gleason grading system is a powerful tool to prognosticate and aid in the treatment of men with prostate cancer. The needle biopsy Gleason score correlates…”
Get full text

Criteria and indicators to evaluate quality of care in genitourinary tumour boards by Puente, Javier, Algaba Arrea, Ferrán, Buisán Rueda, Óscar, Castellano Gauna, Daniel, Durán, Ignacio, Fernández Ávila, Juan José, Gómez-Iturriaga, Alfonso, Parada Blázquez, Mariano José, Pérez Fentes, Daniel, Sancho Pardo, Gemma, Vallejo Casas, Juan Antonio, Gratal, Paula, Pardo, María Teresa, Guillem Porta, Vicente

“…Purpose Genitourinary (GU) multidisciplinary tumour boards (GUMTBs) are key components of patient care, as they might lead to changes in treatment plan,…”
Get full text

Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors by Palou, Juan, Rodríguez-Rubio, Federico, Millán, Félix, Algaba, Ferran, Rodríguez-Faba, Oscar, Huguet, Jorge, Villavicencio, Humberto

“…Objectives To evaluate the risk factors for disease progression in the frequent subgroup of Stage T1G2 (World Health Organization 1973) bladder tumors using an…”
Get full text

Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors by Del Rey, Javier, Prat, Esther, Ponsa, Immaculada, Lloreta, Josep, Gelabert, Antoni, Algaba, Ferran, Camps, Jordi, Miró, Rosa

“…Aneuploidy, centrosome abnormalities and gene amplification are hallmarks of chromosome instability (CIN) in cancer. Yet there are no studies of the in vivo…”
Get full text

Molecular Lymph Node Staging in Bladder Urothelial Carcinoma: Impact on Survival by Marín-Aguilera, Mercedes, Mengual, Lourdes, Burset, Moisès, Oliver, Artur, Ars, Elisabet, Ribal, María José, Colomer, Dolors, Mellado, Begoña, Villavicencio, Humberto, Algaba, Ferran, Alcaraz, Antonio

“…Abstract Background Routine histologic analysis of lymph nodes (LN) for detecting disseminated bladder urothelial carcinoma (BUC) lacks sensitivity. Objective…”
Get full text

Identification of PMF1 Methylation in Association with Bladder Cancer Progression by Ainel Aleman, Virginia Cebrian, Miguel Alvarez, Virginia Lopez, Esteban Orenes, Lidia Lopez-Serra, Ferran Algaba, Joaquin Bellmunt, Antonio López-Beltrán, Pilar Gonzalez-Peramato, Carlos Cordon-Cardo, Javier García, Javier García del Muro, Manel Esteller, Marta Sánchez-Carbayo

“…Purpose: Polyamines are important regulators of cell growth and death. The polyamine modulated factor-1 (PMF-1) is involved in polyamine homeostasis. After…”
Get full text

Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography–mass spectrometry and capillary electrophoresis–mass spectrometry metabolomics approach by Alberice, Juliana Vieira, Amaral, Andre F.S., Armitage, Emily Grace, Lorente, José Antonio, Algaba, Ferrán, Carrilho, Emanuel, Márquez, Mirari, García, Antonia, Malats, Núria, Barbas, Coral

“…•Potential metabolic biomarkers have been discovered for bladder cancer with LC–MS and CE–MS.•27 metabolite features were highlighted as significantly…”
Get full text

Criteria for an improved prognostic stratification in category pT renal carcinoma by Algaba, Ferran

“…Asymptomatic renal carcinomas are usually small and localized and thus, for the assessment of pT, precise criteria are required, able to identify the initial…”
Get more information

Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Guérin Response in Patients With T1G3 High-Risk Bladder Tumours by Agundez, Miriam, Grau, Laura, Palou, Joan, Algaba, Ferrán, Villavicencio, Humberto, Sanchez-Carbayo, Marta

“…Abstract Background Bacillus Calmette-Guérin (BCG) is a standard treatment for reducing tumour recurrence and delaying progression of high-risk…”
Get full text

Brief history of the who blue books on urinary and male genital tumours by Algaba, Ferran, Nesi, Gabriella

Get full text

Grading of prostate cancer. For a more precise prognosis by Algaba, Ferran

“…The simplification of the Gleason grading system, together with the reclassification of some of its patterns, has improved correlation with the clinical…”
Get more information